BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7804984)

  • 1. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
    Dalmau J; Graus F; Cheung NK; Rosenblum MK; Ho A; Cañete A; Delattre JY; Thompson SJ; Posner JB
    Cancer; 1995 Jan; 75(1):99-109. PubMed ID: 7804984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
    Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
    J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic anti-Hu serum: studies on human tumor cell lines.
    Verschuuren JJ; Dalmau J; Hoard R; Posner JB
    J Neuroimmunol; 1997 Nov; 79(2):202-10. PubMed ID: 9394793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface expression of paraneoplastic encephalomyelitis/sensory neuronopathy-associated Hu antigens in small-cell lung cancers and neuroblastomas.
    Torà M; Graus F; de Bolòs C; Real FX
    Neurology; 1997 Mar; 48(3):735-41. PubMed ID: 9065557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice.
    Sillevis Smitt PA; Manley GT; Posner JB
    Neurology; 1995 Oct; 45(10):1873-8. PubMed ID: 7477985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.
    Keime-Guibert F; Graus F; Broët P; Reñé R; Molinuevo JL; Ascaso C; Delattre JY
    Neurology; 1999 Nov; 53(8):1719-23. PubMed ID: 10563618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues.
    Dalmau J; Furneaux HM; Cordon-Cardo C; Posner JB
    Am J Pathol; 1992 Oct; 141(4):881-6. PubMed ID: 1415481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome.
    Sodeyama N; Ishida K; Jaeckle KA; Zhang L; Azuma A; Yamada M; Mizusawa H; Wada Y
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):97-9. PubMed ID: 9886463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
    Manley GT; Smitt PS; Dalmau J; Posner JB
    Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
    Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
    J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
    Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
    Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation.
    Vega F; Graus F; Chen QM; Poisson M; Schuller E; Delattre JY
    Neurology; 1994 Nov; 44(11):2145-7. PubMed ID: 7969974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.
    Voltz R; Dalmau J; Posner JB; Rosenfeld MR
    Neurology; 1998 Oct; 51(4):1146-50. PubMed ID: 9781545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues.
    Nabors LB; Furneaux HM; King PH
    J Neuroimmunol; 1998 Dec; 92(1-2):152-9. PubMed ID: 9916890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory neuronopathy and small cell lung cancer: antineuronal antibody reacting with neuroblastoma cells.
    Lövblad KO; Boucraut J; Bourdenet S; Burger D; Bernard D; Regli F; Steck AJ
    J Neurol; 1993 Jun; 240(6):327-32. PubMed ID: 8393093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HuD paraneoplastic protein shares immunogenic regions between PEM/PSN patients and several strains and species of experimental animals.
    Sillevis Smitt P; Manley G; Dalmau J; Posner J
    J Neuroimmunol; 1996 Dec; 71(1-2):199-206. PubMed ID: 8982120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour.
    Voltz RD; Posner JB; Dalmau J; Graus F
    J Neurol Neurosurg Psychiatry; 1997 Aug; 63(2):133-6. PubMed ID: 9285445
    [No Abstract]   [Full Text] [Related]  

  • 19. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy.
    Molinuevo JL; Graus F; Serrano C; Reñe R; Guerrero A; Illa I
    Ann Neurol; 1998 Dec; 44(6):976-80. PubMed ID: 9851446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
    Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J
    Clin Cancer Res; 1998 Nov; 4(11):2819-24. PubMed ID: 9829748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.